Podcasts

Carey August, MD, FCAP, gives members a preview of the free executive leadership workshop happening this Saturday, April 26, in Washington, DC.

E. Randy Eckert, MD, FCAP, Chair of the CAP's Political Action Committee (PathPAC), shares how personal contributions support PathPAC's mission.

Diana M. Cardona, MD, MBA, FCAP, Vice Chair of the Council on Government and Professional Affairs and a member of the CAP's Board of Governors, explains why it's important for pathologists to attend the summit and join their colleagues on Capitol Hill later this month.

A new workshop to help pathologists grow their influence through strategic leadership is on the agenda when members of the College of American Pathologists meet in Washington, DC, this month.

If you're concerned about the impact of federal policy on you and your patients, then you need to make time to be among those who visit the nation’s capital April 26–29. Mary Le, MD, FCAP, Chair of the CAP's Federal and State Affairs Committee, previews the CAP's federal policy agenda.

A. Joe Saad, MD, CPE, FCAP, Chair of the CAP's Council on Government and Professional Affairs, discusses why members should attend and prepare for the CAP's premier advocacy and leadership event in April. 

Sang Wu, MD, FCAP, speaker of the CAP House of Delegates, says delegates are ready to make their voices heard at this year's House of Delegates & Pathologists Leadership Summit.

M. E. (Doc) de Baca, MD, FCAP, Chair of the CAP's Council on Informatics and Pathology Innovation and a member of the CAP's Board of Governors, discusses the Council’s accomplishments in 2024 and priorities in 2025.

Kalisha Hill, MD, MBA, FCAP, FASCP, Chair of the CAP's Council on Education and a member of the CAP's Board of Governors discusses the educational wins in 2024 and Council priorities for 2025.

Guillermo Martinez-Torres, MD, FCAP, Chair of the Council on Membership and Professional Development, and a member of the CAP’s Board of Governors, discusses successes in 2024 and Council priorities for the new year.

Earle S. Collum, MD, FCAP, Chair of the CAP's Council on Accreditation, discusses the CAP's recent accreditation accomplishments and gives a preview of accreditation priorities for 2025.

Listen to CAP President Donald Karcher, MD, FCAP, share why pathologists should attend the annual Pathologists Leadership Summit and his experience advocating for pathologists and patients on Capitol Hill.

Leading the development of new proficiency testing programs for laboratories, the publication of new research, and tracking threats to public health are at the top of the scientific agenda at the College of American Pathologists.

Daniel Owens, Vice President of the Royal College of Pathologists of Australasia visits Washington, DC, to learn about the CAP's advocacy work in the nation's capital.

In this special episode, Council on Government and Professional Affairs Chair Joe Saad, MD, CPE, FCAP highlights a year of advocacy legislative wins and 2025 legislative priorities.

Cancer PathCHART is a groundbreaking initiative redefining cancer surveillance standards. Discover how Cancer PathCHART ensures more accurate data, improves cancer research, and enhances public health—all while supporting pathologists and cancer registrars in their critical roles.

Dr. Alison Van Dyke and Dr. Darrell Kirch share their journeys through mental health challenges and discuss the pervasive issue of physician burnout. With a focus on breaking the stigma, they explore the importance of seeking help, fostering open conversations, and building supportive communities. They also highlight systemic changes in medical training and healthcare environments that promote wellness.

Dr. Juanita Evans interviews Dr. Michael Williams on his journey of building a platform to amplify diverse voices in pathology. Together, they discuss the challenges and triumphs of fostering inclusivity in healthcare, highlighting how representation reshapes patient care, medical education, and the future of medicine.

Insurer interference is on the rise, creating barriers for patients to access medical care. Insurer interference often happens under the guise of cost-cutting measures for patients, but pathologists report an increase in disruptions to providing timely diagnosis and medical care for their patients.

Dr. Joel Moncur is joined by a panel of distinguished experts to discuss the groundbreaking journey of molecular proficiency testing programs, including next-generation sequencing (NGS). Drs. Wayne Grody, Karl Voelkerding, and Jason Merker discuss the impact these programs have on laboratories, patient care, and regulatory compliance, as well as the role of molecular pathology in shaping the future of health care.